Fidelity Investments’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
Fidelity Investments's IRMD Position: Q2 2026 in Review
Fidelity Investments increased its iRadimed (IRMD) stake by 6.9% in Q2 2026, buying an estimated $424K and bringing the position to 71,720 shares worth $6.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2291.
Fidelity Investments first reported a position in IRMD in Q1 2022 and has held it in 18 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Fidelity Investments held 71,720 shares of iRadimed worth $6.85M as of Q2 2026.
- Fidelity Investments bought 4,651 iRadimed shares in Q2 2026, an estimated $424K.
- iRadimed made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2291 holding.
- Fidelity Investments first reported a position in iRadimed in Q1 2022 and has held it in 18 quarters since.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.